Traditional Chinese medicine syndromes for essential hypertension: A literature analysis of 13,272 patients

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Wang, Jie ^a   Xiong, Xingjiang ^a   Liu, Wei ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIBLIOGRAPHIC DATABASE; CHINESE MEDICINE; CLINICAL FEATURE; EMBASE; ESSENTIAL HYPERTENSION; HEMOSTASIS; HUMAN; KIDNEY DISEASE; LIVER DISEASE; MEDLINE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SPLEEN DISEASE; SYNDROME; YANG DEFICIENCY; YIN DEFICIENCY;

EID: 84896100274     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/418206     Document Type: Review

References (144)

1. Slama M., Susic D., Frohlich E. D., Prevention of hypertension. Current Opinion in Cardiology 2002 17 5 531 536 2-s2.0-0036753496 10.1097/00001573- 200209000-00014 (Pubitemid 35265792)
2. Calhoun D. A., Zaman M. A., Nishizaka M. K., Resistant hypertension. Current Hypertension Reports 2002 4 3 221 228 2-s2.0-0036617257
3. Roger V. L., Lloyd-Jones D. M., Go A. S., Heart disease and stroke statistics 2011 update: a report from the American Heart Association. Circulation 2011 123 e118 e209
4. Kearney P. M., Whelton M., Reynolds K., Muntner P., Whelton P. K., He J., Global burden of hypertension: analysis of worldwide data. Lancet 2005 365 9455 217 223 2-s2.0-12344282783 10.1016/S0140-6736(05)17741-1 (Pubitemid 40138015)
5. Lloyd-Jones D., Adams R., Carnethon M., Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009 119 3 480 486 10.1161/CIRCULATIONAHA.108.191259
6. Su D., Li L., Trends in the use of complementary and alternative medicine in the United States: 2002-2007. Journal of Health Care for the Poor and Underserved 2011 22 1 296 310 2-s2.0-79951658749
7. Ching S. M., Zakaria Z. A., Paimin F., Complementary alternative medicine use among patients with type 2 diabetes mellitus in the primary care setting: a cross-sectional study in Malaysia. BMC Complementary and Alternative Medicine 2013 13 article 148 10.1186/1472-6882-13-148
8. Hawk C., Ndetan H., Evans M. W., Potential role of complementary and alternative health care providers in chronic disease prevention and health promotion: an analysis of National Health Interview Survey data. Preventive Medicine 2012 54 1 18 22 2-s2.0-84855492930 10.1016/j.ypmed.2011.07.002
9. Xiong X. J., Yang X. C., Liu W., Banxia baizhu tianma decoction for essential hypertension: a systematic review of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine 2012 2012 10 271462 10.1155/2012/271462
10. Xiong X. J., Yang X. C., Feng B., Zhen gan xi feng decoction, a traditional Chinese herbal formula, for the treatment of essential hypertension: a systematic review of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine 2013 2013 9 982380 10.1155/2013/982380
11. Wang J., Yang X. C., Feng B., Is yangxue qingnao granule combined with antihypertensive drugs, a new integrative medicine therapy, more effective than antihypertensive therapy alone in treating essential hypertension? Evidence-Based Complementary and Alternative Medicine 2013 2013 8 540613 10.1155/2013/540613
12. Tam W. Y., Chook P., Qiao M., Cardiovascular protective effects of adjunctive alternative medicine (Salvia miltiorrhiza and Pueraria lobata) in high-risk hypertension. Evidence-Based Complementary and Alternative Medicine 2013 2013 8 132912 10.1155/2013/132912
13. Xu H., Chen K. J., Complementary and alternative medicine: is it possible to be main stream? Chinese Journal of Integrative Medicine 2012 18 403 404 10.1007/s11655-012-1126-7
14. Ferreira A. S., Lopes A. J., Chinese medicine pattern differentiation and its implications for clinical practice. Chinese Journal of Integrative Medicine 2011 17 11 818 823 2-s2.0-84858383319
15. Wang J., Xiong X. J., Liu W., Yoga for essential hypertension: a systemic review. PloS ONE 2013 8 10 e76357 10.1371/journal.pone.0076357
16. Lee M. S., Lim H. J., Lee M. S., Impact of qigong exercise on self-efficacy and other cognitive perceptual variables in patients with essential hypertension. Journal of Alternative and Complementary Medicine 2004 10 4 675 680 2-s2.0-4444353827 10.1089/1075553041829442 (Pubitemid 39167315)
17. Wang J., Feng B., Yang X. C., Tai Chi for Essential Hypertension. Evidence-Based Complementary and Alternative Medicine 2013 2013 10 215254 10.1155/2013/215254
18. Wang J., Xiong X. J., Outcome measures of Chinese herbal medicine for hypertension: an overview of systematic reviews. Evidence-Based Complementary and Alternative Medicine, 2012 2012 7 697237 10.1155/2012/697237
19. Xiong X. J., Yang X. C., Liu Y. M., Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern science. Hypertension Research 2013 36 570 579 10.1038/hr.2013.18
20. Wang J., Feng B., Yang X. C., Tianma gouteng yin as adjunctive treatment for essential hypertension: a systematic review of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine 2013 2013 18 706125 10.1155/2013/706125
21. Wang J., Feng B., Yang X. C., Liu W., Xiong X., Chinese herbal medicine for the treatment of prehypertension. Evidence-Based Complementary and Alternative Medicine 2013 2013 9 493521 10.1155/2013/493521
22. Chen K. J., Mao ZD and integrative medicine. Zhongguo Zhong Xi Yi JieHe Za Zhi 1993 13 2 711 713
23. Wang J., Yao K. W., Yang X. C., Chinese patent medicine liu wei di huang wan combined with antihypertensive drugs, a new integrative medicine therapy, for the treatment of essential hypertension: a systematic review of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine 2012 2012 7 714805 10.1155/2012/714805
24. Wang J., Feng B., Xiong X. J., Chinese herbal medicine for the treatment of obesity-related hypertension. Evidence-Based Complementary and Alternative Medicine 2013 2013 11 757540 10.1155/2013/757540
25. Wang J., Xiong X. J., Current situation and perspectives of clinical study in integrative medicine in China. Evidence-Based Complementary and Alternative Medicine 2012 2012 11 268542 10.1155/2012/268542
26. Chen K. J., Jiang Y. R., Xie Y. H., Past and present of combination of disease differentiation and syndrome differentiation. Zhongguo Zhong Xi Yi Jie He Za Zhi 2011 31 4 437 443
27. Xu H., Chen K. J., Integrating traditional medicine with biomedicine towards a patient-centered healthcare system. Chinese Journal of Integrative Medicine 2011 17 2 83 84 2-s2.0-79952558248 10.1007/s11655-011-0641-2
28. Chen S. L., Liu X. Y., Xu W. M., Mei W. Y., Chen X. L., Clinical study of western medicine combined with Chinese medicine based on syndrome differentiation in the patients with polarized hypertension. Chinese Journal of Integrative Medicine 2012 18 10 746 751 10.1007/s11655-012-1231-7
29. Liu L., Leung E. L. H., Tian X., Perspective: the clinical trial barriers. Nature 2011 480 7378 S100 2-s2.0-84055184878 10.1038/480S100a
30. Dobos G., Tao I., The model of Western Integrative Medicine: the role of Chinese medicine. Chinese Journal of Integrative Medicine 2011 17 1 11 20 2-s2.0-79952542879 10.1007/s11655-011-0601-x
31. Xiong X. J., Chu F. Y., Li H. X., He Q. Y., Clinical application of the TCM classic formulae for treating chronic bronchitis. Journal of Traditional Chinese Medicine 2011 31 1 69 72 2-s2.0-79956160524
32. Wang J., Xiong X., Control strategy on hypertension in Chinese medicine. Evidence-Based Complementary and Alternative Medicine 2012 2012 6 2-s2.0-84855609561 10.1155/2012/284847 284847
33. Wang J., Xiong X. J., Yang G. Y., Chinese herbal medicine qi ju di huang wan for the treatment of essential hypertension: a systematic review of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine 2013 2013 10 262685 10.1155/2013/262685
34. Tian P., Convergence: where West meets East. Nature 2011 480 supplement 7378 S84 S86 2-s2.0-84055184876 10.1038/480S84a
35. Wang J., Xiong X., Control strategy on hypertension in Chinese medicine. Evidence-Based Complementary and Alternative Medicine 2012 2012 6 2-s2.0-84855609561 10.1155/2012/284847 284847
36. Wang J., Wang P. Q., Xiong X. J., Current situation and re-understanding of syndrome and formula syndrome in Chinese medicine. Internal Medicine 2012 2 3 1000113
37. Xu H., Chen K., Integrative medicine: the experience from China. Journal of Alternative and Complementary Medicine 2008 14 1 3 7 2-s2.0-38749126248 10.1089/acm.2006.6329 (Pubitemid 351185427)
38. Cheung F., TCM: made in China. Nature 2011 480 7378 S82 S83 2-s2.0-84055193535 10.1038/480S82a
39. Xiong X. J., Yang X. C., Liu W., Trends in the treatment of hypertension from the perspective of traditional Chinese medicine. Evidence-Based Complementary and Alternative Medicine 2013 2013 13 275279 10.1155/2013/275279
40. Lu A. P., Jia H. W., Xiao C., Lu Q. P., Theory of traditional Chinese medicine and therapeutic method of diseases. World Journal of Gastroenterology 2004 10 13 1854 1856 2-s2.0-3543098689 (Pubitemid 39029278)
41. Zhao Q. G., Li H., Yang H. M., Difference of urine protein during the stage of early renal damage in elderly primary hypertensive patients with different yraditional Chinese Medical syndrome types: an analysis of 122 cases. Journal of Chinese Medicine 2012 44 7 25 27
42. Liu F. M., Chen X. H., Du W. Q., Correlativity between ACE Gene I/D polymorphism and TCM syndromes of primary hypertension. Shanghai Journal of Traditional Chinese Medicine 2009 43 11 33 35
43. Wang X. Y., Xie Z. Q., Ji L. L., Clinical research of amlodipine combined Xingqi huoxue decoction on 99 elderly patients with qi stagnation and bood stasis hypertension. Chinese Medicine Modern Distance Education of China 2012 10 13 81 82
44. Luo F. H., Li G. H., Li Q. L., Clinical research on syndrome differentiation of point application in the treatment of primary hypertension. China Medical Herald 2011 8 21 108 112 10.3969/j.issn.1673-7210.2011.21.047
45. Wang C. H., Gao Y., Chen J. Z., Effect of syndrome differentiation and treatment combined alisma decoction on traditional Chinese medicine symptom integral of hypertension. Global Traditional Chinese Medicine 2012 5 7 538 540
46. Wang Y. S., Lin Z. H., Chen H. C., Clinical research on the treatment of early hypertensive renal damage by tonifying kidney and invigorating the circulation of blood. Traditional Chinese Medicine Journal 2011 10 5 52 54
47. Bai C. J., Zhou Y., Wang L., Zhang D. L., Yang Y., Delamination of cardiovascular risk factor, staging and grading of hypertension and the changing characteristics of blood lipids and hemorheological indexes in hypertensive patients with different syndromes of traditional Chinese medicine. Chinese Journal of Clinical Rehabilitation 2005 9 23 145 147 2-s2.0-27744592976 (Pubitemid 41581507)
48. Yang L. J., Yao L., Liu A. F., Relation study between erythrocyte immunological function and serum SOD activity of hypertension patients with different typing. Modern Journal of Integrated Traditional Chinese and Western Medicine 2005 14 13 1676 1677
49. Xia C. X., Yang Q. Y., Zhu H. J., Correlation study on different TCM syndromes of primary hypertension and NO/NOS system, ET21, left ventricular mass index (BMI). Chinese Journal of Integrative Medicine on Cardio/Cerebrovascular Disease 2010 8 1 32 33
50. Liu Z. Y., Wu H. L., Luo Y., The effect of shenmai injection dealing with insufficient relaxation of left ventricle caused by hypertension. Chinese Journal of Chinese Medicine Information 2003 10 4 16 18
51. Yin W. H., Liu J. L., Clinical observation on treatment of 53 cases with essential hypertension by deficiency syndrome. Inner Mongolia Medical Journal 2005 37 6 536 537
52. Wu R., Zhao F. D., Yu S. J., Research of different type of traditional medical syndromes on hypertension disease with regularity of blood pressure variability. Chinese Journal of Chinese Medicine Emergency 2010 19 3 443 445
53. Deng H. F., Analysis of effect on compound danshen dropping pill compared with sheng tong ping in patients with hypertension. Asia-Pacific Traditional Medicine 2008 4 10 46 48
54. Wu L. Q., Xu F. Q., Study on the relationship between type of syndrome of high-risk hypertensive patients and target organ damage and the risk factors of cardiovascular events. Chinese Journal of Integrative Medicine on Cardio/Cerebrovascular Disease 2010 8 12 1409 1410
55. Wang W., Li F. Q., Li Y. P., Study on the relationship between Syndrome differentiation type of hypertension and Angiotensin original gene M 235T and T 174M polymorphisms. Journal of Zhejiang Traditional Chinese Medicine 2011 46 9 628 629
56. Wu D. M., Chen X. H., Liu F. M., Studying of relationship between arteriosclerosis of essential hypertension and TCM syndromes. Journal of Chinese Medicine in Inner Mongolia 2010 3 1 2
57. Fan Q. L., Liu F. M., Studying of relationship between ambulatory blood pressure of hypertension and syndrome differentiation type of TCM. Jilin Journal of TCM 2010 30 10 859 860
58. Zhu W., Li S. J., Ruan X. M., Study on the relationship between arterial compliance and syndrome differentiation typing in hypertensive patients. Lishizhen Medicine and Materia Medica Research 2009 20 1 38 40
59. Liu F. M., Chen X. H., Du W. Q., Clinical research on the distribution regularity of TCM syndrome types. Journal of Chinese Medicine in Jiangsu 2009 41 10 33 34
60. He S. Y., Fu D. Y., Zu L. H., Correlation of traditional Chinese medicine syndromes with B-type natriuretic peptide and the risk of stroke in patients with essential hypertension: a preliminary study. China Journal of Traditional Chinese Medicine and Pharmacy 2013 28 1 281 284
61. Tang J. Y., Wang Y. H., Tang N., Correlativity between Patterns of Hypertension in TCM and Polymorphism of COX-2. Shanghai Zhongyiyao Daxue Xuebao 2012 26 3 32 35
62. Gong N. J., Li Q., Chen J., A correlated study between TCM syndrome and cardiac structural functional changes in patients with primary hypertension. Tianjin Journal of Traditional Chinese Medicine 2010 27 1 19 21
63. Zhang C., Xing Z. H., Liu W. P., Relativity investigation of plasma endothelin and blood pressure in patients with hypertension with different traditional Chinese medical classification. Liaoning Journal of TCM 2005 32 1 6 8
64. Liu F. M., Du W. Q., Shen L., A correlated study between left ventricular hypertrophy of hypertension and TCM syndrome type. Liaoning Journal of TCM 2009 44 12 871 872
65. Wang J. Y., A correlated study between syndrome differentiation type of TCM and ambulatory blood pressure. Medical Laboratory Sciences 2012 3 143 144
66. Yao M. M., Huang T. J., A correlated study between syndrome differentiation type of TCM and blood uric acid. Fujian Journal of TCM 2007 38 5 9 11
67. Guo L. L., Zhou Y., Zhuang T. T., Relationship between the endothelin/nitric oxide and hypertension with traditional Chinese medical classification. Guizhou Medical Journal 2002 26 6 502 504
68. Zhang J. Z., Chen L. G., Hu X. Q., Influence of astragalus polysaccharide on the expression of Toll-like receptor 4 and nuclear transcription factor-k B in essential hypertension patients with blood stasis syndrome. Journal of Traditional Chinese Medicine 2011 52 15 1286 1304
69. Liao W. Q., Huang W. M., He B., Observation on insulin resistance of essential hypertension treated by the therapeutic method of activating blood circulation to dissipate Blood Stasis. Chinese Journal of Information on TCM 2010 17 9 9 11
70. Xiong Y. W., Clinical effect of the modified banxia baizhu tianma decoction combining western medicine on 60 patients with phlegm-dampness type primary hypertension. Chinese Medicine Modern Distance Education of China 2010 8 13 67 68
71. Jiang C. X., Cao J. M., Xu J. Y., Clinical research on effects of the renin-angiotensin-II of senile patients with high blood pressure by jianling decoction. Chinese Journal of Science and Technology of Chinese Medicine 2012 19 2
72. Huang Z. C., Wei Q. P., Curative effect analysis on identifying treatment of resistant hypertension combined with the system of traditional Chinese medicine. Chinese Community Doctors 2012 14 35 192 193
73. Lu X., Clinical research on the treatment of patients with liver-kidney yin deficiency of hypertension by qiju dihuang wan decoction. Xinjiang Journal of Chinese Medicine 2004 22 5 20 22
74. Sun H. T., Wang C., Different manifestations of cognitive dysfunction in hypertensive patients with different syndromes of traditional Chinese medicine. Chinese Journal of Clinical Rehabilitation 2005 9 20 63 65 2-s2.0-27644532565 (Pubitemid 41575706)
75. Xiang Y., Bai G. C., Wu L. M., Syndrome differentiation type and of nursing modern of community of primary hypertension. Hebei Journal of TCM 2012 34 5 766 768
76. Zhu D. X., The effect of injected Ligustrazine to shenshu point in patients with hypertension. China Practical Medicine 2009 4 15 38 40
77. Xu C. Y., Wang F. L., Clinical observation of hypertensive effect of taichong acupoint injection with ligustrazine on hypertension. Occupations and Health 2009 25 18 2000 2002
78. Lin M., Kang N. S., Study on carotid ultrasound of phlegm dampness syndromes compared with yang hyperactivity syndromes of not intervention in primary hypertension. Journal of Shandong University of TCM 2012 36 2 115 117
79. Feng H., Liu Z. C., Xu B., Clinical observation on the treatment of 36 cases of excessive accumulation of phlegm-dampness of essential hypertension complicated by obesity by warm acupuncture. Journal of Anhui TCM College 2013 32 1 47 50
80. Yu A. W., Xing E. H., Clinical observation on the treatment of 90 cases with hypertension by Xifeng Tongluo Huayu decoction. Journal of Sichuan of TCM 2010 28 3 74 76
81. Qiu C., Cheng X. D., Cheng F. K., Clinical observation on the treatment of senile hypertension by Yiqihuoxue decoction. Hebei Journal of TCM 2011 33 6 838 839
82. Wu T. C., Xu T., Clinical observation on the treatment of 60 cases of senile hypertension by tonifying qi and yin. Yunnan Journal of TCM 2012 33 4 31 33
83. Fang X. M., Huang X. Y., Wang Q., Research of clustering analysis of syndrome differentiation type of hypertension. Guangxi Journal of TCM 2007 30 5 9 11
84. Fang W., Chen T. L., Zhu G. L., Research on the syndrome differentiation type of primary hypertension and the characteristics of dynamic blood pressure changes. Zhejiang Journal of TCM 2003 4 164 166
85. Peng L. L., Shi D. Z., Analysis on syndromes elements of primary hypertension with depression. Beijing Journal of TCM 2010 29 7 534 536
86. Yang H. Y., Jin Y. R., Yang H., Relationship between the syndrome differentiation type of hypertension and ambulatory blood pressure. Chinese Journal of Information TCM 2004 11 1 23 46
87. Shi X. L., Wen Z. L., Zhang N., Clinical investigation on related factors and rule of the type of distribution of primary hypertension with depression. Jiangsu Journal of TCM 2013 45 2 25 26
88. Han Y. M., Clinical study on the treatment of primary hypertension based on syndrome differentiation of TCM. Health Guides of the International Medical 2004 10 10 120 122
89. Shen R., Chen Y. D., Zhang Z. X., Exploring the correlation of syndrome differentiation of primary hypertension and heart rate variability. China Journal of Traditional Chinese Medicine and Pharmacy 2008 23 5 453 455
90. Shen Y., Zhang J. D., Hu L. H., The relatirity of insulin resistance and syndrome differentiation typing in essential hypertension. Journal of Shandong University 2005 43 2 142 145
91. Liu X. L., Wei A. L., Luo F., Ultrasound study of carotid artery plaque score and the carotid intinamedia thickness in essential hypertension with traditional chinese medical classification. Liaoning Journal of TCM 2009 36 5 689 692
92. Lu X., Wei C. Y., Yang L. H., Study on the relationship between syndrome type of TCM of primary hypertension and apolipoprotein. Journal of Guangxi Traditional Chinese Medical University 2011 14 3 4 6
93. Guo K. F., Zhang J. F., Yang W. Q., Relationships between personality characteristic and diff erentiation of symptom and sign for classification of syndrome of traditional Chinese medicine in patients with primary hypertension. Chinese Journal of Cardiovascular Rehabilitation Medicine 2006 15 4 326 328
94. Zhang J. P., Yuan H. W., Wang H. L., Correlation between concentration of β 2 microglobulin in blood and urine in patients with primary hypertension and traditional Chinese medicine syndrome. Hebei Journal of TCM 2012 34 5 658 660
95. Dong C. W., Dong M., Xing Q. S., Relationship between polymorphism of angiotensin converting enzyme gene and different traditional Chinese medicine syndrome in patients with essential hypertension. Chinese Journal of Pathophysiology 2010 26 8 1545 1548
96. Zhang Z. B., Zhou C. G., Lu S., Distribution of TCM syndrome types of essential hypertension and their relationship to biochemical indicators. Liaoning Journal of TCM 2010 37 6 969 972
97. Chen J., Chen Z. Q., Clinical study on characteristics of changes in dynamic blood pressure in patients with primary hypertension of blood stasis syndrome. World Journal of Integrated Traditional and Western Medicine 2008 3 10 600 603
98. Liu L., Zhang Y. Q., A correlated study between HCY, MAU and TCM syndrome type of hypertension. Heilongjiang Journal of TCM 2010 5 5 7
99. Zhou X., Clinical effect analysis on treating 86 cases of essential hypertension with treatment based on differentiation of symptoms and signs. Clinical Journal of Chinese Medicine 2013 5 3 55 57
100. Chen G. Y., Wang L. J., Liu J., Relationship between TCM syndrome types and related risk factors of essential hypertension. Chinese Journal of Information on TCM 2012 19 11 16 18
101. Zhou W. Q., Liu D. H., Dai Y. N., Study on the correlation between the related factors and TCM syndromes of essential hypertension with left ventricular hypertrophy. Journal of Traditional Chinese Medicine 2009 50 3 248 250
102. Ding Y. X., Zhou Y. X., Liu B., Preliminary analysis on epidemiological characteristics of TCM syndromes of primary hypertension in Guangdong region. Journal of Anhui TCM College 2009 28 2 25 27
103. Li Z. W., Clinical observation on the treatment of 125 cases of essential hypertension complicated by syndrome differentiation and treatment of TCM. Forum on Traditional Chinese Medicine 2002 17 2 31 33
104. Qiu Z. F., Clinical observation on the treatment of 97 cases of essential hypertension by syndrome differentiation of TCM. Chinese Journal of Ethnomedicine and Ethnopharmacy 2010 3 187 189
105. Deng W. L., Zhao G., Clinical observation on syndrome differentiation of TCM of 80 cases of the hypertension patients with left ventricular hypertrophy. Xinjiang Journal of TCM 2004 22 5 20 22
106. Chen Q., Clinical study on primary hypertension early time kidney harm with Zishuiqingganyin. Chinese Archives of TCM 2010 28 6 1332 1335
107. Zhang T. W., Zheng B. R., Clinical observation on the treatment of 30 cases of essential hypertension with liver-yang hyperactivity by " Jiangya 2" Fujian Medical Journal 2009 31 6 133 135
108. Wan Y. X., Zhang T. Z., Research on relationship between angiotensinogen gene M235T and TCM syndrome type in essential hypertension patients. Chinese Journal of Integrated Traditional and Western Medicine 2008 28 1 36 38 2-s2.0-55949120726
109. Xu Y. J., Zhang T. Z., Relationship of day and night rhythm of Essential Hypertension with TCM Syndrome patterns. Journal of New Chinese Medicine 2008 40 5 41 43
110. Zhang D., Li H. R., Epidemiological investigation and distribution of TCM syndrome of primary hypertension in community. The Community of Chinese Medicine 2010 12 229 83
111. Pu Z. H., Yang G. D., Ding T. Y., Clinical observation on the effect of blood pressure, cholesterol, blood sugar, and the clinical syndromes of traditional Chinese medicine of 220 cases of essential hypertension by "Ping ganyin" capsule. China Journal of Chinese Materia Medica 2008 33 10 1202 1205
112. Cheng W. J., Tan Z. C., Guo F., Epidemiological studies on TCM syndrome of 602 cases of primary hypertension. Chinese Journal of Integrated Traditional and Western Medicine 2003 13 4 261 263
113. Ding B. Y., Shao Z. B., Zheng L., Study on the relationship between early nephritic injures by essential hypertension and traditional Chinese medicine syndrome patterns. Journal of Anhui TCM College 2006 5 4 6 8
114. Fu S., Li Y. L., Establishing standards of measuring essential hypertension with hyperactive of liver-Yang syndrome based on multivariate analysis of statistics. Journal of Shandong University of TCM 2010 34 1 14 16
115. Pan Q., Liu Z. D., Chen L. P., Shiliangcha Prescription of "She medicine" combined with western medicine in treating essential hypertension of damp-phlegm pattern: a report of 30 cases. Shanghai Journal of TCM 2012 46 3 49 51
116. Chen G. L., Wang B. Y., Liu H. P., Survey on traditional Chinese medicine syndrome types in 471 patients with essential hypertension. Journal of Anhui TCM College 2011 30 4 24 26
117. Zhao Y. H., Liu Y. D., Huang P. G., Effects of clinical treatment and protection on endothelial function of early essential hypertension's patients treated with YNJY soup in southern Guangdong area. China Journal of Traditional Chinese Medicine and Pharmacy 2009 24 9 1148 1150
118. Zhou C. G., Zhang Z. B., Xia C. X., Association of the C-344T polymorphism of CY P11 B2 gene with TCM syndrome type in essential hypertension. Liaoning Journal of TCM 2010 37 4 577 579
119. Huang J. H., Zheng Q. S., Gao R., Clinical equivalence evaluation on the efficacy and safety of Niuhuang jiangya tablets and pills in the treatment of patients with primary hypertension (overabundant liver-fire). Chinese Journal of Evidence-Based Medicine 2004 4 4 249 251
120. Lu X., Clinical observation on the treatment of essential hypertension by compound Danshen dripping pills. Journal of Guangxi Traditional Chinese Medical University 2004 2 28 29
121. Zhu D., Lin S. B., Clinical observation on the treatment of essential hypertension with yin deficiency and yang excess by Zishui pinggan decoction. Chinese Journal of Geriatric Care 2012 10 4 32 35
122. Wang C. H., Gao Y., Chen J. Z., Impact analysis of syndrome differentiation combined with modified Zixie decoction for hypertension symptoms. World Chinese Medicine 2013 8 3 285 287
123. Ji D. G., Ling kok uncaria decoction in the treatment of hypertension. Journal of Chinese Herbs of TCM 2011 18 10 92 93
124. Yuan L., Tu D., Ye X., Wu J., Hypoglycemic and hypocholesterolemic effects of Coptis chinensis franch inflorescence. Plant Foods for Human Nutrition 2006 61 3 139 144 2-s2.0-33749665999 10.1007/s11130-006-0023-7 (Pubitemid 44554870)
125. Koo H. J., Lim K. H., Jung H. J., Park E. H., Anti-inflammatory evaluation of gardenia extract, geniposide and genipin. Journal of Ethnopharmacology 2006 103 3 496 500 2-s2.0-31344449552 10.1016/j.jep.2005.08. 011 (Pubitemid 43143390)
126. Ho S. C., Ho Y. F., Lai T. H., Liu T. H., Wu R. Y., Traditional Chinese herbs against hypertension enhance the effect of memory acquisition. American Journal of Chinese Medicine 2005 33 5 787 795 2-s2.0-24944577353 10.1142/S0192415X05003326 (Pubitemid 41319928)
127. Zhou J., Zhou S., Antihypertensive and neuroprotective activities of rhynchophylline: the role of rhynchophylline in neurotransmission and ion channel activity. Journal of Ethnopharmacology 2010 132 1 15 27 2-s2.0-77957807953 10.1016/j.jep.2010.08.041
128. Hansen K., Nyman U., Smitt U. W., Adsersen A., Gudiksen L., Rajasekharan S., Pushpangadan P., In vitro screening of traditional medicines for anti-hypertensive effect based on inhibition of the angiotensin converting enzyme (ACE). Journal of Ethnopharmacology 1995 48 1 43 51 2-s2.0-0029116828 10.1016/0378-8741(95)01286-M
129. Gu J., Wang J. J., Yan J., Cui C. F., Wu W. H., Li L., Wang Z. S., Yu M., Gao N., Liu L., Ouyang D. S., Effects of lignans extracted from Eucommia ulmoides and aldose reductase inhibitor epalrestat on hypertensive vascular remodeling. Journal of Ethnopharmacology 2011 133 1 6 13 2-s2.0-78650679272 10.1016/j.jep.2010.08.055
130. Li L., Yan J., Hu K., Gu J., Wang J. J., Deng X. L., Li H., Jing X., Li Z. Y., Ye Q. F., Ouyang D. S., Protective effects of Eucommia lignans against hypertensive renal injury by inhibiting expression of aldose reductase. Journal of Ethnopharmacology 2012 139 2 454 461 2-s2.0-84856013738 10.1016/j.jep.2011. 11.032
131. Greenway F., Liu Z., Yu Y., Gupta A., A clinical trial testing the safety and efficacy of a standardized Eucommia ulmoides oliver bark extract to treat hypertension. Alternative Medicine Review 2011 16 4 338 347 2-s2.0-84857407106
132. Han Y. P., Wang N. S., Mi S. Q., Liu Q. D., Effect of Wuling Powder on rats with renal hypertension. Zhong Xi Yi Jie He Xue Bao 2003 1 4 285 288 2-s2.0-16544362834
133. Chen J. Y., Fan H. L., Zhang S. F., Effect of modified Zexie decoction on prevention of kidney injuries of rats with hypertension induced by high-salt diet. Zhong Yi Za Zhi 2012 53 3 234 237
134. Wu S. J., Ng L. T., Lin C. C., Antioxidant activities of some common ingredients of traditional Chinese medicine, Angelica sinensis, Lycium barbarum and Poria cocos. Phytotherapy Research 2004 18 12 1008 1012 2-s2.0-14044278027 10.1002/ptr.1617 (Pubitemid 40278927)
135. Sun Y., Wang S., Li T., Li X., Jiao L., Zhang L., Purification, structure and immunobiological activity of a new water-soluble polysaccharide from the mycelium of Polyporus albicans (Imaz.) Teng. Bioresource Technology 2008 99 4 900 904 2-s2.0-36048969749 10.1016/j.biortech.2007.01.029 (Pubitemid 350088459)
136. Yuan R., Lin Y., Traditional Chinese medicinean approach to scientific proof and clinical validation. Pharmacology and Therapeutics 2000 86 2 191 198 2-s2.0-0033625056 10.1016/S0163-7258(00)00039-5 (Pubitemid 30229901)
137. Jiang W. Y., Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science. Trends in Pharmacological Sciences 2005 26 11 558 563 2-s2.0-27144432852 10.1016/j.tips.2005.09.006 (Pubitemid 41505223)
138. Kim D. D., Sánchez F. A., Durán R. G., Kanetaka T., Durán W. N., Endothelial nitric oxide synthase is a molecular vascular target for the Chinese herb Danshen in hypertension. American Journal of Physiology-Heart and Circulatory Physiology 2007 292 5 H2131 H2137 2-s2.0-34250830191 10.1152/ajpheart.01027.2006 (Pubitemid 47084591)
139. Hou Y. Z., Zhao G. R., Yuan Y. J., Zhu G. G., Hiltunen R., Inhibition of rat vascular smooth muscle cell proliferation by extract of Ligusticum chuanxiong and Angelica sinensis. Journal of Ethnopharmacology 2005 100 1-2 140 144 2-s2.0-23144464199 10.1016/j.jep.2005.01.051 (Pubitemid 41078737)
140. Simeonova R. L., Vitcheva V. B., Kondeva-Burdina M. S., Krasteva I. N., Nikolov S. D., Mitcheva M. K., Effect of purified saponin mixture from Astragalus corniculatus on enzyme- and non-enzyme-induced lipid peroxidation in liver microsomes from spontaneously hypertensive rats and normotensive rats. Phytomedicine 2010 17 5 346 349 2-s2.0-76749125275 10.1016/j.phymed.2009.08.013
141. Xue B., Li J., Chai Q., Liu Z., Chen L., Effect of total flavonoid fraction of Astragalus complanatus R. Brown on angiotensin II-induced portal-vein contraction in hypertensive rats. Phytomedicine 2008 15 9 759 762 2-s2.0-48649099014 10.1016/j.phymed.2007.11.030
142. Yao L. M., Liu T. W., Wu W. F., Effects of Astragalus injection in reversing left ventricular hypertrophy induced by renal hypertension in rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 2009 29 10 918 921
143. Lin L. Z., He X. G., Lian L. Z., King W., Elliott J., Liquid chromatographic-electrospray mass spectrometric study of the phthalides of Angelica sinensis and chemical changes of Z-ligustilide. Journal of Chromatography A 1998 810 1-2 71 79 2-s2.0-0031808344 10.1016/S0021-9673(98) 00201-5 (Pubitemid 28288229)
144. Hou Y. Z., Zhao G. R., Yang J., Yuan Y. J., Zhu G. G., Hiltunen R., Protective effect of Ligusticum chuanxiong and Angelica sinensis on endothelial cell damage induced by hydrogen peroxide. Life Sciences 2004 75 14 1775 1786 2-s2.0-3242682465 10.1016/j.lfs.2004.05.005 (Pubitemid 38961800)